Search

Drug Profiles Catalysts Company Profiles Impact Events Target
Indication Trials KOL Insight Special Reports All

Drug Impact Events

Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
10/22/14 Relypsa (RLYP) Patiromer for Hyperkalemia Subscribers Only Subscribers Only Subscribers Only
10/22/14 Regulus (RGLS) RG-101 for Hepatitis C (HCV) (Antiviral) Subscribers Only Subscribers Only Subscribers Only
10/22/14 Alkermes (ALKS) Aripiprazole Lauroxil (monthly) for Schizophrenia Subscribers Only Subscribers Only Subscribers Only
10/21/14 Roche (ROG:VX) Basimglurant for Major Depressive Disorder (MDD) Subscribers Only Subscribers Only Subscribers Only
10/21/14 Vertex Pharmaceuticals (VRTX) Kalydeco for Cystic Fibrosis (CF) Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

Expected
Date Range
Lead
Company
Drug Expected
Catalyst
Now - 10/23/14 Subscribers Only Subscribers Only Company - Earnings Announcement
10/23/14 Subscribers Only Subscribers Only Company - Earnings Announcement
10/23/14 Subscribers Only Subscribers Only Company - Earnings Announcement
10/23/14 Subscribers Only Subscribers Only Company - Earnings Announcement
10/23/14 Subscribers Only Subscribers Only Company - Earnings Announcement